Beiersdorf AG’s US division points to communications straight from FDA in its motion to dismiss a proposed class action alleging that a NIVEA “firming” lotion is an unapproved drug in violation of federal and California laws.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?